Skip to main content
Article

Repeat endovascular treatment of recurring hepatic artery stenoses in orthotopic liver transplantation

Danièle SommacaleDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation; Hospital Beaujon; Clichy; FranceTakeshi AoyagiDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation; Hospital Beaujon; Clichy; FranceFédérica DonderoDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation; Hospital Beaujon; Clichy; FranceAnnie SibertDepartment of Radiology; Hospital Beaujon; Clichy; FranceOnorina BrunoDepartment of Radiology; Hospital Beaujon; Clichy; FranceSamir Fadhel FtéricheDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation; Hospital Beaujon; Clichy; FranceClaire FrancozDepartment of Hepatology; Hospital Beaujon; Clichy; FranceFrançois DurandDepartment of Hepatology; Hospital Beaujon; Clichy; FranceJacques BelghitiDepartment of Hepatopancreatobiliary Surgery and Liver Transplantation; Hospital Beaujon; Clichy; France
2013en
ABI

Abstract

Hepatic artery stenosis (HAS) is a complication that impacts the results of orthotopic liver transplantation (OLT). Interventional radiological techniques are important therapeutic options for HAS. The aim of this retrospective study was to evaluate the outcome of repeated radiological treatments in recurring HAS after OLT. Of the 941 patients who underwent OLT at our center from January 1998 to September 2010, 48 (5%) were diagnosed with HAS, 37 (77%) of whom underwent transluminal interventional therapy with the placement of an endovascular stent. Success rate, complications, hepatic artery patency and follow-up were reviewed. After stent placement, artery patency was achieved in all patients. Three patients developed complications, including arterial dissection and hematoma. HAS recurrence was observed in 9 patients (24%), and hepatic artery thrombosis (HAT) occurred in 4 (11%). Radiological interventions were repeated 10 times in 8 patients without complications. At a median follow-up of 66 months (range 10-158), hepatic artery patency was observed in 35 cases (94.6%). The 5-year rates for graft and patient survival were 82.3% and 87.7%, respectively. Restenosis may occur in one-third of patients after endovascular treatment for thrombosis and HAS, but the long-term outcomes of iterative radiological treatment for HAS indicate a high rate of success.

Identifiers

Citations and references

Cited by 20 references